Novavax becomes fifth COVID-19 vaccine developer to release promising early results
The candidate vaccine seems to have generated an immune reaction similar to those in people who have recovered from COVID-19, the data shows.
Novavax becomes fifth COVID-19 vaccine developer to release promising early results
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Canada strikes more deals for COVID-19 vaccine, but may have to wait in line behind other nations
National Post
Capping a flurry of procurement announcements Monday, the federal government made a bold claim: Canada would be at the “front of..
-
Tesla and Apple carry the Nasdaq into the green as Wall Street closes out strong month
Proactive Investors
-
NA Proactive news snapshot: NexTech AR, DGTL Holdings, Power Ore, Gevo UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Media Central, BioLargo, Loop Insights, Progressive Planet UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Empower Clinics, MindMed, Falcon Gold, Trillion Energy, EXMceuticals ...
Proactive Investors
Advertisement
More coverage
Novavax skyrockets 23% after saying its COVID-19 vaccine showed promising results in an early trial (NVAX)
Business Insider
· *On Tuesday, Novavax announced that its COVID-19 vaccine "elicited robust antibody responses" in an early stage clinical..
-
Dillard's, Novavax rise; Baidu, DraftKings fall
SeattlePI.com
-
'Paranoid about the pandemic': How COVID-19 brought the 'largest criminology experiment in history'
National Post
-
Novavax COVID-19 vaccine elicits robust immune response in early trial
DNA
-
China spat may be threatening Canada's bid to get early access to leading COVID-19 vaccine: experts
National Post